首页 >
法规速递
-
Document: Agenda of the PRAC meeting 1-4 September 2025-2025/9/1
2025-09-02查看详情 > -
Page: Maximum residue limits (MRL)-2025/10/6
2025-10-08查看详情 > -
Document: European medicines regulatory network incident management plan for medicines for human use-2025/11/13
2025-11-14查看详情 > -
国家药监局关于同意吉林、海南省药监局开展优化药品补充申请审评审批程序改革试点的批复-2025/12/10
2025-12-11查看详情 > -
关于将ONC201胶囊纳入《儿童抗肿瘤药物研发鼓励试点计划（星光计划）》试点项目的公示-2026/1/22
2026-01-23查看详情 > -
Document: European Medicines Agency (EMA) stakeholder relations management framework-2026/2/26
2026-02-27查看详情 > -
Page: Grouping of variations: questions and answers-2026/3/27
2026-03-30查看详情 > -
Page: Revamp of marketing authorisation assessment templates-2026/5/8
2026-05-09查看详情 > -
CVM GFI #95 (VICH GL12) Effectiveness of Anthelmintics: Specific Recommendations for Bovines-2026/6/23
2026-06-24查看详情 > -
关于公开征求《与恶性肿瘤治疗相关中药新药复方制剂临床研发技术指导原则（征求意见稿）》意见的通知-2022/11/17
2022-11-25查看详情 >
